| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.TRIM.2014.08.006 |
| P698 | PubMed publication ID | 25195091 |
| P2093 | author name string | E A van de Graaf | |
| H G Otten | |||
| K Budding | |||
| P2860 | cites work | Cytokine profiles of cultured microvascular endothelial cells from the human intestine | Q24670764 |
| LUNG HOMOTRANSPLANTATION IN MAN | Q28191021 | ||
| HIF-1α signaling by airway epithelial cell K-α1-tubulin: role in fibrosis and chronic rejection of human lung allografts | Q28395914 | ||
| Characterization of the endothelial cell cytoskeleton following HLA class I ligation | Q28478778 | ||
| Pros and cons for C4d as a biomarker | Q30544649 | ||
| Identification of non-HLA target antigens recognized after lung transplantation | Q33267044 | ||
| Role of complement in enterohemorrhagic Escherichia coli-Induced hemolytic uremic syndrome. | Q33415084 | ||
| Identification of Non-HLA antigens targeted by alloreactive antibodies in patients undergoing chronic hemodialysis | Q33523853 | ||
| Anti-human leukocyte antigen antibodies and preemptive antibody-directed therapy after lung transplantation | Q34079631 | ||
| A revised model for the secretion of tPA and cytokines from cultured endothelial cells | Q34184742 | ||
| Characterization of immune responses to cardiac self-antigens myosin and vimentin in human cardiac allograft recipients with antibody-mediated rejection and cardiac allograft vasculopathy | Q34238488 | ||
| Dendritic cells in transplantation--friend or foe? | Q34241103 | ||
| Mechanisms of airway obliteration after lung transplantation | Q34541743 | ||
| Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria | Q34565524 | ||
| Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection | Q34728157 | ||
| The role of mannose-binding lectin in health and disease | Q35563974 | ||
| Antibody to human leukocyte antigen triggers endothelial exocytosis | Q35611613 | ||
| Role of autoimmunity in organ allograft rejection: a focus on immunity to type V collagen in the pathogenesis of lung transplant rejection | Q35769939 | ||
| Long-term exposure of chemokine CXCL10 causes bronchiolitis-like inflammation | Q35987153 | ||
| Cumulative exposure to gamma interferon-dependent chemokines CXCL9 and CXCL10 correlates with worse outcome after lung transplant | Q36090184 | ||
| Antibodies to K-α 1 tubulin and collagen V are associated with chronic rejection after lung transplantation | Q36131035 | ||
| Type V collagen: molecular structure and fibrillar organization of the chicken alpha 1(V) NH2-terminal domain, a putative regulator of corneal fibrillogenesis | Q36232905 | ||
| Allograft rejection after lung transplantation | Q36303269 | ||
| Terminal complement proteins C5b-9 release basic fibroblast growth factor and platelet-derived growth factor from endothelial cells | Q36362882 | ||
| Molecular basis for a link between complement and the vascular complications of diabetes | Q36977373 | ||
| C4d deposition without rejection correlates with reduced early scarring in ABO-incompatible renal allografts | Q37042154 | ||
| A role for antibodies to human leukocyte antigens, collagen-V, and K-α1-Tubulin in antibody-mediated rejection and cardiac allograft vasculopathy | Q37044200 | ||
| Bronchiolitis obliterans syndrome: alloimmune-dependent and -independent injury with aberrant tissue remodeling | Q37245242 | ||
| Acute rejection and humoral sensitization in lung transplant recipients | Q37365017 | ||
| HLA class I antibody-mediated endothelial and smooth muscle cell activation | Q37430871 | ||
| Immunology mini-review: the basics of T(H)17 and interleukin-6 in transplantation | Q38008077 | ||
| The role of complement in the early immune response to transplantation. | Q38013049 | ||
| Incompatible kidney transplantation: a brief overview of the past, present and future. | Q38036246 | ||
| Paroxysmal nocturnal hemoglobinuria and the complement system: recent insights and novel anticomplement strategies | Q38080869 | ||
| Upregulation of chemokines in bronchoalveolar lavage fluid as a predictive marker of post-transplant airway obliteration | Q38287405 | ||
| Chronic rejection of a lung transplant is characterized by a profile of specific autoantibodies | Q38346048 | ||
| Human leukocyte antigen mismatches predispose to the severity of bronchiolitis obliterans syndrome after lung transplantation | Q38353796 | ||
| Anti-HLA class I antibody binding to airway epithelial cells induces production of fibrogenic growth factors and apoptotic cell death: a possible mechanism for bronchiolitis obliterans syndrome | Q38355651 | ||
| Anti-BPIFA1/SPLUNC1: a new autoantibody prevalent in patients with endstage cystic fibrosis | Q39309059 | ||
| Anti-HLA class I antibody-mediated activation of the PI3K/Akt signaling pathway and induction of Bcl-2 and Bcl-xL expression in endothelial cells | Q40560932 | ||
| Activation of human airway epithelial cells by non-HLA antibodies developed after lung transplantation: a potential etiological factor for bronchiolitis obliterans syndrome | Q40806790 | ||
| Airway epithelial cell damage mediated by antigen-specific T cells: implications in lung allograft rejection | Q40841738 | ||
| Pre-transplant anti-epithelial cell antibodies and graft failure after single lung transplantation | Q41366720 | ||
| Antibodies to MHC class I induce autoimmunity: role in the pathogenesis of chronic rejection. | Q42126102 | ||
| Cytomegalovirus infection and pneumonitis. Impact after isolated lung transplantation. Washington University Lung Transplant Group | Q43677913 | ||
| Posttransplant major histocompatibility complex class I chain-related gene A antibodies and long-term graft outcomes in a multicenter cohort of 779 kidney transplant recipients. | Q44015961 | ||
| C4d staining of pulmonary allograft biopsies: an immunoperoxidase study | Q44403426 | ||
| Post-transplant obliterative bronchiolitis and other late lung sequelae in human heart-lung transplantation | Q45039146 | ||
| HLA class I signal transduction is dependent on Rho GTPase and ROK. | Q45047333 | ||
| Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection | Q45259438 | ||
| Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions | Q45342440 | ||
| Lung transplantation in patients with pretransplantation donor-specific antibodies detected by Luminex assay. | Q46001225 | ||
| Multicenter evaluation of a novel endothelial cell crossmatch test in kidney transplantation | Q46077973 | ||
| Differential Immunogenicity and Clinical Relevance of Kidney Compartment Specific Antigens after Renal Transplantation | Q46188986 | ||
| ABO blood group-incompatible living donor kidney transplantation: a prospective, single-centre analysis including serial protocol biopsies | Q46410666 | ||
| Upper lobe fibrosis: a novel manifestation of chronic allograft dysfunction in lung transplantation. | Q47733483 | ||
| The Registry of the International Society for Heart and Lung Transplantation: Thirtieth Adult Lung and Heart-Lung Transplant Report--2013; focus theme: age. | Q48164895 | ||
| Antivimentin antibodies are an independent predictor of transplant-associated coronary artery disease after cardiac transplantation. | Q50674616 | ||
| HLA-A locus mismatches and development of antibodies to HLA after lung transplantation correlate with the development of bronchiolitis obliterans syndrome. | Q50899711 | ||
| Humorally mediated posttransplantation septal capillary injury syndrome as a common form of pulmonary allograft rejection: a hypothesis. | Q51696388 | ||
| Survival determinants in lung transplant patients with chronic allograft dysfunction. | Q53208316 | ||
| Identification of the antibodies involved in B-cell crossmatch positivity in renal transplantation. | Q53860170 | ||
| Comparative study on signal transduction in endothelial cells after anti-a/b and human leukocyte antigen antibody reaction: implication of accommodation. | Q54538215 | ||
| Vascular deposition of complement-split products in kidney allografts with cell-mediated rejection | Q67773387 | ||
| Obliterative bronchiolitis after lung and heart-lung transplantation. An analysis of risk factors and management | Q71873465 | ||
| Capillary deposition of C4d complement fragment and early renal graft loss | Q72791721 | ||
| Activation of NF-kappa B in human endothelial cells induced by monoclonal and allospecific HLA antibodies | Q73615692 | ||
| Risk factors for the development of bronchiolitis obliterans syndrome after lung transplantation | Q73624720 | ||
| C3D deposition in peritubular capillaries indicates a variant of acute renal allograft rejection characterized by a worse clinical outcome | Q73678539 | ||
| Association of humoral immunity and bronchiolitis obliterans syndrome | Q73810384 | ||
| Development of ELISA-detected anti-HLA antibodies precedes the development of bronchiolitis obliterans syndrome and correlates with progressive decline in pulmonary function after lung transplantation | Q77415463 | ||
| Prevention of bronchiolitis obliterans in rat lung allografts by type V collagen-induced oral tolerance | Q77754722 | ||
| Evidence That Humoral Allograft Rejection in Lung Transplant Patients Is Not Histocompatibility Antigen-Related | Q79083547 | ||
| Antibodies against MICA antigens and kidney-transplant rejection | Q81357717 | ||
| De novo development of circulating anti-endothelial cell antibodies rather than pre-existing antibodies is associated with post-transplant allograft rejection | Q82082999 | ||
| Restrictive allograft syndrome (RAS): a novel form of chronic lung allograft dysfunction | Q83653731 | ||
| C3d and the septal microvasculature as a predictor of chronic lung allograft dysfunction | Q83832015 | ||
| Antibody-mediated rejection in lung transplantation: myth or reality? | Q83908463 | ||
| The impact of non-HLA antibodies directed against endothelin-1 type A receptors (ETAR) on early renal transplant outcomes | Q86635362 | ||
| A new classification system for chronic lung allograft dysfunction | Q87008531 | ||
| P433 | issue | 4 | |
| P921 | main subject | lung transplant | Q1637912 |
| P304 | page(s) | 260-265 | |
| P577 | publication date | 2014-09-03 | |
| P1433 | published in | Transplant Immunology | Q15758510 |
| P1476 | title | Humoral immunity and complement effector mechanisms after lung transplantation | |
| P478 | volume | 31 |
| Q51578868 | A Promoter Polymorphism in the CD59 Complement Regulatory Protein Gene in Donor Lungs Correlates With a Higher Risk for Chronic Rejection After Lung Transplantation. |
| Q90733042 | A Single Nucleotide C3 Polymorphism Associates With Clinical Outcome After Lung Transplantation |
| Q52714977 | Description of human AAA by cytokine and immune cell aberrations compared to risk-factor matched controls. |
| Q51044254 | Divergent Function of Programmed Death-Ligand 1 in Donor Tissue versus Recipient Immune System in a Murine Model of Bronchiolitis Obliterans. |
| Q41631328 | Lung-Restricted Antibodies Mediate Primary Graft Dysfunction and Prevent Allotolerance after Murine Lung Transplantation |
| Q38645385 | Potential Roles for C1 Inhibitor in Transplantation |
| Q50042914 | Reduced Expression of Membrane Complement Regulatory Protein CD59 on Leukocytes following Lung Transplantation |
| Q61814286 | The Autoimmune-Associated Single Nucleotide Polymorphism Within Correlates With Clinical Outcome After Lung Transplantation |
Search more.